AURA Aura Biosciences, Inc.
Aura Biosciences, Inc. (AURA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $39.0M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Gibney Anthony S | See Remarks | Sell | 12,824 | $6.42 | $82.3K | 265,354 −4.6% of holding | |
| Sell | 6,922,870 | $5.64 | $39.0M | None left | |||
| Kilroy Conor | See Remarks | Sell | 11,738 | $7.02 | $82.4K | 217,835 −5.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.